Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Director Jennifer Straumins Sells 37,861 Shares of Stock

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Director Jennifer Straumins sold 37,861 shares of Calumet Specialty Products Partners stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $21.42, for a total value of $810,982.62. Following the transaction, the director now owns 1,184,589 shares of the company’s stock, valued at $25,373,896.38. The trade was a 3.10 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Jennifer Straumins also recently made the following trade(s):

• On Tuesday, November 12th, Jennifer Straumins sold 100,000 shares of Calumet Specialty Products Partners stock. The shares were sold at an average price of $20.59, for a total value of $2,059,000.00.

Calumet Specialty Products Partners Trading Up 0.4 %

NASDAQ:CLMT opened at $20.39 on Friday. Calumet Specialty Products Partners, L.P. has a twelve month low of $9.97 and a twelve month high of $25.29. The company has a market cap of $1.75 billion, a P/E ratio of -7.39 and a beta of 1.91. The company’s 50-day moving average price is $21.32 and its 200-day moving average price is $18.09.

Calumet Specialty Products Partners (NASDAQ:CLMT) last posted its quarterly earnings results on Friday, November 8th. The oil and gas company reported ($1.18) EPS for the quarter, missing the consensus estimate of ($0.59) by ($0.59). The company had revenue of $1.10 billion during the quarter, compared to analysts’ expectations of $888.36 million. The business’s revenue was down 4.3% on a year-over-year basis. During the same period in the previous year, the company posted $0.03 earnings per share. On average, analysts expect that Calumet Specialty Products Partners, L.P. will post -2.87 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. StockNews.com raised shares of Calumet Specialty Products Partners to a “sell” rating in a report on Monday, November 18th. TD Cowen lowered their target price on shares of Calumet Specialty Products Partners from $27.00 to $26.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. HC Wainwright restated a “buy” rating and issued a $25.00 price target on shares of Calumet Specialty Products Partners in a research note on Monday, November 11th. Finally, Wells Fargo & Company increased their price target on Calumet Specialty Products Partners from $25.00 to $29.00 and gave the stock an “overweight” rating in a research report on Monday, October 21st. One research analyst has rated the stock with a sell rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $23.75.

Institutional Investors Weigh In On Calumet Specialty Products Partners

Hedge funds have recently modified their holdings of the company. Wedbush Securities Inc. purchased a new stake in shares of Calumet Specialty Products Partners in the 2nd quarter valued at approximately $169,000. Founders Financial Alliance LLC increased its stake in Calumet Specialty Products Partners by 8.4% during the second quarter. Founders Financial Alliance LLC now owns 48,400 shares of the oil and gas company’s stock worth $777,000 after acquiring an additional 3,750 shares during the last quarter. FAS Wealth Partners Inc. raised its position in Calumet Specialty Products Partners by 4.5% in the second quarter. FAS Wealth Partners Inc. now owns 54,126 shares of the oil and gas company’s stock valued at $869,000 after purchasing an additional 2,308 shares during the period. DRW Securities LLC acquired a new position in shares of Calumet Specialty Products Partners in the 2nd quarter valued at $898,000. Finally, Creative Planning grew its holdings in shares of Calumet Specialty Products Partners by 46.4% during the 2nd quarter. Creative Planning now owns 62,459 shares of the oil and gas company’s stock worth $1,002,000 after purchasing an additional 19,800 shares during the period. Hedge funds and other institutional investors own 34.41% of the company’s stock.

About Calumet Specialty Products Partners

Calumet, Inc manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally. It operates through Specialty Products and Solutions; Montana/Renewables; and Performance brands segments.